Related Experiment Video
Updated: May 13, 2026
07:03
In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Paediatric nonalcoholic fatty liver disease
Anna Alisi1, Guido Carpino, Valerio Nobili
1Liver Research Unit, Bambino Gesù Children's Hospital, IRCCS, and Department of Health Sciences, University of Rome Foro Italico, IRCCS, Rome, Italy.
Current Opinion in Gastroenterology
|March 16, 2013
Summary
Pediatric nonalcoholic fatty liver disease (NAFLD) is increasingly common. Recent research highlights unique genetic factors, histological patterns, and tailored treatments for children with this condition.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Metabolic Disorders
Background:
- Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum from simple steatosis to nonalcoholic steatohepatitis (NASH).
- NAFLD has seen epidemic increases in overweight/obese children over the past decade.
- This review focuses on recent advancements in pediatric NAFLD.
Purpose of the Study:
- To review recent advances in pediatric nonalcoholic fatty liver disease (NAFLD).
- To highlight the unique aspects of NAFLD in children compared to adults.
- To discuss current understanding of genetic and pathogenetic origins.
Main Methods:
- Literature review of recent studies on pediatric NAFLD.
- Analysis of findings related to histology, genetics, and pathogenesis.
- Evaluation of diagnostic and management strategies.
Main Results:
- Pediatric NAFLD shares some features with adult NAFLD but has distinct genetic and pathogenetic origins due to fewer confounding factors.
- Histological patterns in children differ from adults, necessitating specific diagnostic and management approaches.
- Lifestyle interventions and pharmacological treatments tailored to pediatric NAFLD patterns are effective.
Conclusions:
- Recent investigations clarify the histological features and genetic background of pediatric NAFLD.
- The role of cellular and organ crosstalk in disease development is increasingly understood.
- Limitations of adult-derived diagnostic tools necessitate further clinical trials for pediatric NAFLD.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...